- Type / Class
- Equity / Common Stock
- Shares outstanding
- 29,067,614
- Total 13F shares
- 25,223,190
- Share change
- +872,436
- Total reported value
- $4,487,798,716
- Put/Call ratio
- 156%
- Price per share
- $177.93
- Number of holders
- 233
- Value change
- +$175,442,652
- Number of buys
- 126
- Number of sells
- 106
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
|
Company |
8.8%
|
2,565,555
|
$318,282,753 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.4%
|
2,435,774
|
$302,182,123 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
8.2%
|
2,385,898
|
$295,994,506 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.2%
|
1,809,547
|
$224,492,402 | — | 31 Dec 2023 | |
| Redmile Group, LLC |
13F
|
Company |
6%
|
1,733,189
|
$215,019,427 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
1,237,497
|
$153,523,878 | — | 31 Dec 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.4%
|
988,460
|
$122,628,348 | — | 31 Dec 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.5%
|
724,344
|
$89,862,116 | — | 31 Dec 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
2.1%
|
618,458
|
$76,726,000 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
550,806
|
$68,336,718 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
511,246
|
$63,433,082 | — | 31 Dec 2023 | |
| Woodline Partners LP |
13F
|
Company |
1.7%
|
481,979
|
$59,794,315 | — | 31 Dec 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.6%
|
474,484
|
$58,864,485 | — | 31 Dec 2023 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.6%
|
458,513
|
$56,883,123 | — | 31 Dec 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
427,363
|
$53,020,000 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
319,721
|
$39,664,623 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
315,465
|
$39,136,588 | — | 31 Dec 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.88%
|
256,604
|
$31,834,292 | — | 31 Dec 2023 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.86%
|
250,470
|
$31,073,000 | — | 31 Dec 2023 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.84%
|
244,061
|
$30,278,208 | — | 31 Dec 2023 | |
| First Turn Management, LLC |
13F
|
Company |
0.83%
|
242,185
|
$30,045,471 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.78%
|
228,053
|
$28,292,255 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.73%
|
213,519
|
$26,489,168 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
209,199
|
$25,953,228 | — | 31 Dec 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.68%
|
196,386
|
$24,363,647 | — | 31 Dec 2023 | |
| BRAIDWELL LP |
13F
|
Company |
0.67%
|
196,200
|
$24,340,572 | — | 31 Dec 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.66%
|
192,875
|
$23,928,073 | — | 31 Dec 2023 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.64%
|
185,809
|
$23,051,000 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
185,038
|
$22,955,814 | — | 31 Dec 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.59%
|
172,879
|
$21,447,369 | — | 31 Dec 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.58%
|
169,934
|
$21,082,012 | — | 31 Dec 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.55%
|
160,335
|
$19,891,160 | — | 31 Dec 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
136,485
|
$16,932,329 | — | 31 Dec 2023 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.42%
|
123,200
|
$15,284,000 | — | 31 Dec 2023 | |
| S Squared Technology, LLC |
13F
|
Company |
0.38%
|
110,215
|
$13,673,273 | — | 31 Dec 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.36%
|
103,969
|
$12,898,394 | — | 31 Dec 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.36%
|
103,700
|
$12,865,022 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
98,651
|
$12,238,685 | — | 31 Dec 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.33%
|
95,958
|
$11,904,549 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.31%
|
91,193
|
$11,313,403 | — | 31 Dec 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.29%
|
85,000
|
$10,545,100 | — | 31 Dec 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.29%
|
84,021
|
$10,423,645 | — | 31 Dec 2023 | |
| Eversept Partners, LP |
13F
|
Company |
0.28%
|
80,798
|
$10,023,800 | — | 31 Dec 2023 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.26%
|
74,945
|
$9,297,677 | — | 31 Dec 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.24%
|
70,901
|
$8,795,978 | — | 31 Dec 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.23%
|
67,141
|
$8,329,512 | — | 31 Dec 2023 | |
| Decheng Capital LLC |
13F
|
Company |
0.23%
|
65,772
|
$8,159,674 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.22%
|
64,179
|
$7,962,047 | — | 31 Dec 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.2%
|
59,324
|
$7,359,735 | — | 31 Dec 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.19%
|
55,000
|
$6,823,609 | — | 31 Dec 2023 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q1 2024
As of 31 Mar 2024,
Krystal Biotech, Inc. - Common Stock (KRYS) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,223,190 shares.
The largest 10 holders included
FMR LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., Redmile Group, LLC, Frazier Life Sciences Management, L.P., STATE STREET CORP, JENNISON ASSOCIATES LLC, PRICE T ROWE ASSOCIATES INC /MD/, and DIMENSIONAL FUND ADVISORS LP.
This page lists
233
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
194
Q1 2024 holders
233
Holder diff
39
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.